Literature DB >> 10935993

Molecular characterisation of HCV genotype 4 isolates circulating in Italy.

C Argentini1, S Dettori, U Villano, V Guadagnino, D Infantolino, P Dentico, R C Coppola, M Rapicetta.   

Abstract

The characteristics of genotype 4 subtype variability of HCV isolates circulating in Italy were studied. The viral isolates were identified from 736 HCV-RNA positive sera originated from seroepidemiological studies undertaken in 4 different regions of North, South Italy and Sardinia. 24 out of 28 genotype 4 isolates (86%) were classified by phylogenetic analysis of E1 genome region (915-1128) as belonging to subtype 4d (Neighbour Joining Method). Three isolates classified as subtype 4a were detected in haemophilic patients, possibly related to infections from blood products. One isolate classified as a new subtype derived from an Eritrean patient subjected to haemodialysis. Very high genome homogeneity (mean 4.3%) was shown by genetic comparisons (DNA dist programs Phylip Package) for all the 4d isolates relative to the studies performed in Veneto, Calabria and Sardinia and originated from subjects from the general population and outpatients (19 subtype 4d isolates out of 24). In the 3 studies different prevalence rates of HCV genotype 4 (3.1%, 1. 3%, 14% respectively) were found. In contrast a considerable degree of heterogeneity, both intragroup and with the other groups (mean 8. 2% and 8.7%, respectively) was observed among subtype 4d isolates identified in the patients of a haemodialysis centre in Apulia region. In conclusion the subtype 4d of genotype 4 was highly prevalent and endemic in Italy. An elevated level of viral heterogeneity was observed in one study carried out in a region of Southern Italy. This can be related to a longer period of past endemicity of this genotype and to a high level of exposure to reinfections in particular categories of patients such as haemodialysis patients. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10935993     DOI: 10.1002/1096-9071(200009)62:1<84::aid-jmv13>3.0.co;2-e

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 2.  Current status and emerging challenges in the treatment of hepatitis C virus genotypes 4 to 6.

Authors:  Vasilios Papastergiou; Stylianos Karatapanis
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

3.  Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis.

Authors:  D Genovese; S Dettori; C Argentini; U Villano; P Chionne; M Angelico; M Rapicetta
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 4.  Viral hepatitis in hemodialysis: An update.

Authors:  Bassam Bernieh
Journal:  J Transl Int Med       Date:  2015-09-30

Review 5.  Phylogeny and phylodinamic of Hepatitis C in Italy.

Authors:  Massimo Ciccozzi; Alessandra Lo Presti; Anna Rita Ciccaglione; Gianguglielmo Zehender; Marco Ciotti
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090

6.  Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients.

Authors:  Stefania Paolucci; Loretta Fiorina; Antonio Piralla; Roberto Gulminetti; Stefano Novati; Giorgio Barbarini; Paolo Sacchi; Marta Gatti; Luca Dossena; Fausto Baldanti
Journal:  Virol J       Date:  2012-10-24       Impact factor: 4.099

7.  An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants.

Authors:  Lin Gu; Wangxia Tong; Manqiong Yuan; Teng Lu; Chunhua Li; Ling Lu
Journal:  J Clin Virol       Date:  2013-05-21       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.